chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT CAME IN TO RECEIVE THEIR COVID VACCINE AND THE FLU VACCINE. TECHNICIAN VERIFIED WITH THE IMMUNIZATION SELECTION TOOL AND ENTERED INTO COMPUTER THE CORRECT VACCINATIONS. THE PHARMACIST ADMINISTERING THE VACCINES HAD GRABBED THE PEDIACTRIC DOSE OF THE COVID INSTEAD OF THE ADULT DOSE.  ONE TECHNICIAN WAS SCANNING THE INFORMATION INTO THE SYSTEM WHEN WE NOTICED THE VACCINE STICKER WAS INCORRECT FOR THE PATIENT, WE IMMEDIATELY NOTIFIED THE PHARMACIST AND THEN HE PROCEEDED TO CALL THE PATIENT AND CDC.
STROKE; This spontaneous report received from a patient via media via a company representative concerned a patient of unspecified age and sex and unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown expiry: unknown) dose was not reported, start therapy date were not reported 1 total administered for prophylactic vaccination (dose number series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced stroke. It was reported that " yes just stick up your ass , I had stroke after I coerced into taking your vaccine". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211157095-COVID-19 VACCINE AD26.COV2.S-Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
After 1st dose of the vaccine she had a sore arm; 1st dose of the vaccine she had a sore arm that was a little swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (After 1st dose of the vaccine she had a sore arm) and VACCINATION SITE SWELLING (1st dose of the vaccine she had a sore arm that was a little swollen) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (After 1st dose of the vaccine she had a sore arm) and VACCINATION SITE SWELLING (1st dose of the vaccine she had a sore arm that was a little swollen). At the time of the report, VACCINATION SITE PAIN (After 1st dose of the vaccine she had a sore arm) and VACCINATION SITE SWELLING (1st dose of the vaccine she had a sore arm that was a little swollen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was taking blood thinners concomitantly.   This case was linked to MOD-2021-359999, MOD-2021-359939 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Oct-2021: Follow up received and contains no new information.
pt recv vax 4APR97 & 14APR97 pt devel a fine German measles-type rash, which was disseminated on face & trunk, sl fever & sl lethargy;20APR97 pt recovered;
This spontaneous report was received from a medical assistant and refers to multiple patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On an unknown dates, the patients' were vaccinated with improperly stored VAQTA (dose, strength, route, frequency, lot # and indication unknown) (incorrect product storage). The vaccine was exposed to high of 9.5 degree Celsius temperature for a time frame of 24 hours. No adverse events were reported. Data logger was involved. It was reported that there was no previous temperature excursion. No product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Shivering, mild fever, muscle pain, fatigue; Treated with Acetaminophen, rest, Ibuprofen; outcome not known yet as it's only 22 hours later
I was really tired and congested. Those were my main symptoms which started late in the afternoon. By Friday I was very tired and by that evening, I was not feeling well at all. I did a video visit to talk about PAXLOVID but did not take it. I completed a COVID-19 home test on February 18, 2023, which was positive did take prednisone for the symptoms. I really didn't cough at all or run a fever. I was only feeling bad for 1 or 2 days. The fourth day I felt fine.
The nurse informed that on 28-AUG-2014 the patient was vaccinated with M-M-R II (strength, dosage and route were not reported) lot number: K001231 expiration date: 27-JAN-2016. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the M-M-R II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was at any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Initial unsolicited report received from a consumer via other company (Pfizer) (Manufacturer report number: 2016137196) on 14 March 2016. This case involves a female patient (age was not reported) who was vaccinated with a dose Flu Vaccine (batch number, dose, expiration date, site and route of administration were not reported) on an unspecified date (reported as last year). The patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient had local reaction at the site of injection and got sick. Lab data and corrective treatment were not reported. Outcome of events was not reported. It was reported that the doctor believed that it may be due to a preservative in the multidose vial of the flu vaccine. List of documents held by sender: none.
little pain in bones; developed a spot on his left hand (on his pinky finger) like a bluish purple color resembles a; a little bit of muscle pain; very little headache; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (developed a spot on his left hand (on his pinky finger) like a bluish purple color resembles a), BONE PAIN (little pain in bones), MYALGIA (a little bit of muscle pain) and HEADACHE (very little headache) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 030A21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, ACETYLSALICYLIC ACID (ASPIRIN EC), ZINC, VITAMIN D3 and ASCORBIC ACID, CHONDROITIN SULFATE SODIUM, GLUCOSAMINE SULFATE, MANGANESE SULFATE (GLUCOSAMINE CHONDROITIN COMPLEX [ASCORBIC ACID;CHONDROITIN SULFATE SODIUM;GLUCOSAMINE SULFATE;MANGANESE SULFATE]) for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced MYALGIA (a little bit of muscle pain) and HEADACHE (very little headache). On 01-Apr-2021, the patient experienced SKIN DISCOLOURATION (developed a spot on his left hand (on his pinky finger) like a bluish purple color resembles a). On 02-Apr-2021, the patient experienced BONE PAIN (little pain in bones). On 02-Apr-2021, SKIN DISCOLOURATION (developed a spot on his left hand (on his pinky finger) like a bluish purple color resembles a), BONE PAIN (little pain in bones) and HEADACHE (very little headache) had resolved and MYALGIA (a little bit of muscle pain) outcome was unknown.            treatment information was not reported. Action taken with mRNA-1273 in response to the event was not applicable. Treatment included heating pad for his muscle pain   Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: Hight, weight, concomitant medications, 1st dose of vaccine, new event and outcome of the events was updated, date of the 2nd vaccine taken was changed.
More than 36 days after first dose without receiving the second dose.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 36 days after first dose without receiving the second dose) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days after first dose without receiving the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 36 days after first dose without receiving the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided.  No treatment information provided by the reporter.   Most recent FOLLOW-UP information incorporated above included on 24-Sep-2021 Follow up received contained Updated demographics, gender female.
Flu-like symptoms; aches and pains; fatigue; chills; headache; This is a spontaneous report from a contactable Other HCP. A 37-year-old non pregnant female patient received BNT162B2 (BNT162B2, Solution for injection, Batch number and Expiry date were not reported) intramuscularly in the right arm on 05Feb2021 10:00 as SECOND DOSE, SINGLE for covid-19 immunisation. The patient medical history included allergy-induced asthma; uterine fibroids; fibrocystic breast disease; chronic sinus issues; migraines; associated with pregnancy (2017-18): pre-eclampsia and postpartum anxiety disorder; and allergy to Amoxicillin, Penicillin, CT Scan Reaction dye, Allium family when raw (onions/garlic and all relatives), dust, mold and cat dander. Concomitant medications included Amfetamine aspartate, Amfetamine sulfate, Dexamfetamine saccharate, Dexamfetamine sulfate (ADDERALL XR and ADDERALL QR), Fluticasone Furoate (FLONASE SENSIMIST); Hydroxyzine, ibuprofen and Olly women's multivitamin. Historical vaccine included first dose of BNT162b2 (BNT162B2, Solution for injection, Lot number was not reported), intramuscularly in the left arm on 11Jan2021 10:00 as FIRST DOSE, SINGLE for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered was clinic/facility. On 05Feb2021 at 10:00 PM (beginning at 12 hours after vaccine), the patient experienced 48 hours of flu-like symptoms including aches and pains, fatigue, chills and headache. No treatment was received for the events. The outcome of the events was recovered.  Information on lot/batch number has been requested.  Follow-up (07May2021): Follow-up attempts completed. No further information expected.
2 days after the shot had cropping anxiety (I've only had this style of anxiety after drinking too much caffeine). It's come in strong waves from then ti up now (now being 4 days later)
8 days after the shot was received, I experienced aches, my left are arm very sore (it hurt to lift it), very red arm at injection site and radius, and very swollen
number one DTP/OPV/HIB given 29OCT92 cardiac arrest (SIDS) 30OCT92;
pt recv vax 5NOV97 & 12NOV97 pt exp a vaginal yeast infect;pt had never had a vaginal yeast infect before;
Developed sneezing, tightness of throat, and tingling of the fingers about 7 minutes post vaccination. Continual sneezing, clutching of throat.
got shot and shingles hurt/ suspected vaccination failure; shingles; shingles hurt; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the shingle shot and then the shingles hurt. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
I got a rash. It first appeared as a small red dot that looked like a mosquito or spider bite. Then it became itchy, it gave a burning sensation when touched. It lasted for a few weeks. I had them on my trunk and legs primarily. They quit itching and left the red marks and dots. The dermatologist prescribed a cream, triamcinolone acetonide, that helps to minimize the itching and burning.
Muscle pain at injection site; Muscle pain at injection site; This is a spontaneous report from a non-contactable physician. A 55-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on 04Apr2021 at 17:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced muscle pain (muscle pain), at injection site (vaccination site pain). No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events muscle pain and vaccination site pain were not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
red circle around the injection site; sweated through my sheets; temperature was 103°F; weak; severe chills; heart palpitations; felt shitty; had poor sleep; My arm was sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitations), FEELING ABNORMAL (felt shitty), SLEEP DISORDER (had poor sleep), HYPERHIDROSIS (sweated through my sheets) and BODY TEMPERATURE INCREASED (temperature was 103°F) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE PAIN (My arm was sore at the injection site). On 25-Mar-2021, the patient experienced PALPITATIONS (heart palpitations), FEELING ABNORMAL (felt shitty), SLEEP DISORDER (had poor sleep), ASTHENIA (weak) and CHILLS (severe chills). On 26-Mar-2021, the patient experienced HYPERHIDROSIS (sweated through my sheets) and BODY TEMPERATURE INCREASED (temperature was 103°F). On 29-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red circle around the injection site). At the time of the report, PALPITATIONS (heart palpitations), FEELING ABNORMAL (felt shitty), SLEEP DISORDER (had poor sleep), HYPERHIDROSIS (sweated through my sheets), BODY TEMPERATURE INCREASED (temperature was 103°F), ASTHENIA (weak), CHILLS (severe chills), VACCINATION SITE PAIN (My arm was sore at the injection site) and VACCINATION SITE ERYTHEMA (red circle around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
At about 7:30 pm, I started getting cold chills. I was under 3 heavy blankets with warm clothing and heat packs still shivering.  By 9 pm, body aches had started.  I took a 500 mg tylenol.  The cold chills went away with the tylenol but did nothing for the body aches. At 11:30 pm, I took 200 mg of ibuprofen because my entire body hurt and I was unable to fall asleep or really move much due to the discomfort. The ibuprofen helped reduce the intensity of the body aches but I got very little sleep.  At 6:30 am, the body aches were intense again  and I started getting hot flashes and nausea. My husband called in sick to help care for our 3 young kids.  I took another 200 mg of  ibuprofen  and that reduced the symptoms again. I can now get around the house instead of laying in bed but would not be able to work.  I did not ever have a measurable fever.  I do have a pretty sore arm
A non-serious spontaneous report of "ten month old patient received H1N1 LAIV" was received from a pharmacist/health professional concerning a ten-month-old male. No relevant medical history have been reported for this patient. On 25-Nov-2009, the patient received H1N1, Intranasal. There was no adverse event associated with this medication error; therefore treatment and reporter causality assessments were not applicable and the event was considered resolved.
Information has been received from an "over 60 years" registered nurse who, "had reactions to medications in general" and "about 2 years ago" (in approximately 2008) was vaccinated with a dose of ZOSTAVAX (Merck) (lot #, expire date and route not reported), 0.65 ml. That day (in approximately 2008) the patient developed "a localized reaction". It was about 3mm in size and 'welty' in appearance. There were no laboratory diagnostics studies performed. The patient sought unspecified medical attention. The patient recovered "3 days after it started". No further information is available.
SLIGHTLY ESCALATED HEART RATE; ESCALATED BLOOD PRESSURE; SLIGHT LIGHTHEADEDNESS; CHANGE IN FINGER NAILS COLOR (DARK PINK/PURPLE); CHANGE IN FINGER COLOR (PALE); BLOOD SHOT EYES; TOUGH TO FOCUS; BACK PAIN; CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient does not smoke weed. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced slightly escalated heart rate, escalated blood pressure, slight lightheadedness, change in finger nails color (dark pink/purple), change in finger color (pale), blood shot eyes, tough to focus, back pain, and chills. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 99.8, 98.6. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slightly escalated heart rate, and slight lightheadedness, had not recovered from tough to focus, and chills, and the outcome of blood shot eyes, change in finger color (pale), change in finger nails color (dark pink/purple), back pain and escalated blood pressure was not reported. This report was non-serious.
After an hour of the shot got itchy sore throat. After 8=10 hours "cold" symptoms started. Runny nose, watery eyes, progressed to stuffy nose, light headache, coughing . Symptoms worse at night.
Patient experienced swollen lymph nodes about a week after receiving her vaccine and it's still partially swollen.
1st dose of Shingrix in 2020 and is late for the 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (The patient received first dose Shingrix in year 2020).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose of Shingrix in 2020 and is late for the 2nd dose). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 29-JUN-2023. A pharmacist reported that a patient received the 1st dose of Shingrix in 2020 and was late for the 2nd dose. The reporter consented to follow up. The healthcare professional did not have any patient details and exact date of 1st dose was unknown. The healthcare professional consented to follow-up via postal mail. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination
HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 07-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious.
Narrative:  85 y.o. male patient who received dose #1 of the Moderna COVID vaccine (Lot #013L20A exp 7/8/21) on 1/20/21. Patient was admitted to a hospital on 1/22/21 for an acute GI bleed (taking apixaban). The patient's wife notified the agency that the patient passed on 1/25/21. Agency has requested records from outside hospital but yet to be received. Reaction classified as severe as death occurred following vaccination.
The patient already received the Hep B vaccine the month prior so should have received the DTap and IPV as separate injections.  The Kindrix given was used off label as it is authorized for use in 4-6 year olds.  Patient had a mild fever and was a little lethargic so slept most of the first day but no other adverse effects.  Advised both parents that if they have any additional questions to please contact their provider.